Ipamorelin is a GH secretagogue pentapeptide considered the most selective and 'cleanest' of its class. Unlike GHRP-6 or GHRP-2, it does not cause a notable rise in cortisol, prolactin or appetite, making it the preferred option for anti-aging, fat-loss and recovery protocols without hormonal side effects. It generates a physiological GH pulse similar to the natural one, ideal for prolonged use.
| Target dose | Units | Volume |
|---|---|---|
| 500 mcg (standard) | 10 IU | 0.10 mL |
| Dosis objetivo | Unidades | Volumen |
|---|---|---|
| 500 mcg (estándar) | 10 UI | 0,10 mL |
| Dose cible | Unités | Volume |
|---|---|---|
| 500 mcg (standard) | 10 UI | 0,10 mL |
In research models, Ipamorelin stimulates a physiological GH pulse without the notable rises in cortisol, prolactin or appetite seen with GHRP-6 or GHRP-2, which is why it is described as the 'cleanest' compound of its class. This selectivity makes it of interest for studies on prolonged-use protocols. For research use only.
The 10 mg vial is reconstituted with 2 mL of bacteriostatic water, giving a concentration of 5 mg/mL, or 50 mcg per IU on a U-100 insulin syringe. A standard 500 mcg dose corresponds to 10 IU (0.10 mL). The solution is labeled, refrigerated at 2–8 °C and remains stable for 28 days. For research use only.
Ipamorelin (a GH secretagogue) and CJC-1295 No DAC (a GHRH analog) act on complementary pathways, so research protocols frequently combine them for a synergistic effect on the GH pulse. This classic stack is studied over cycles of 8–16 weeks. For research use only.
Research protocols administer Ipamorelin in a fasted state, with no food 2 hours before or 30 minutes after, because elevated blood glucose and insulin can blunt the GH pulse. Common timing windows are morning fasted, pre-workout and before sleep. For research use only.